קבוצת דם Rh

The Rh antigen is a protein on red blood cell surfaces that classifies blood as Rh-positive or Rh-negative. Its presence or absence is combined with ABO antigens to designate complete blood types, such as A-positive or B-negative. Understanding the Rh factor is essential in transfusion medicine for ensuring blood compatibility.

Unlike the ABO system, plasma does not naturally contain anti-Rh antibodies. Anti-Rh antibodies develop only after exposure to the Rh antigen, triggering an immune response in Rh-negative individuals. This delayed response is why first transfusions with incompatible Rh blood may not cause immediate problems, but subsequent exposures carry greater risk.

When an Rh-negative mother carries an Rh-positive fetus, her immune system may recognize fetal Rh antigens as foreign, producing anti-Rh antibodies. In the first pregnancy, these antibodies typically cause no harm. However, in subsequent pregnancies with Rh-positive fetuses, existing antibodies cross the placenta and attack fetal red blood cells, causing hemolysis and hemolytic disease of the newborn.

RhoGAM is a serum containing anti-Rh antibodies administered to Rh-negative mothers during and after delivery of Rh-positive babies. It prevents the mother's immune system from recognizing fetal Rh antigens as foreign, stopping anti-Rh antibody production. This protective measure significantly reduces the risk of hemolytic disease in future pregnancies.

The Rh antigen status is combined with ABO antigens when reporting blood type. A person with A and Rh antigens is designated A-positive, while someone with A antigens but no Rh antigen is A-negative. This combined classification ensures accurate blood matching for transfusions and identifies potential maternal-fetal incompatibility risks.

Exposure to Rh-positive blood triggers an immune response in Rh-negative individuals, leading to anti-Rh antibody production. This can cause hemolysis, the destruction of red blood cells, resulting in transfusion complications. Subsequent transfusions with Rh-positive blood carry increased risk of severe hemolytic reactions due to existing antibodies.

Incompatible Rh factors between donor and recipient trigger immune responses causing hemolysis and potential life-threatening complications. Proper Rh typing prevents transfusion reactions and is especially vital for Rh-negative recipients who lack natural anti-Rh antibodies. Accurate Rh classification ensures safe blood matching and protects patient health during transfusions.